Treatment of Alzheimer's disease: the beginning of a new era.
Schenk
Dale
D
Chief Scientific Officer, Elan Corporation, 800 Gateway Blvd., South San Francisco, CA 9480, USA. dale.schenk@elan.com
D000544:Alzheimer Disease / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D005544:Forecasting; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D018384:Oxidative Stress / Q000502:physiology
D016229:Amyloid beta-Peptides